Man Group plc slashed its stake in Regeneron Pharmaceuticals by over 40%, unloading 24,377 shares in Q4. Despite this selloff, Regeneron’s stock climbed 3.2%, shrugging off investor jitters like a ...

which tends to hurt stock performance. The strategy also had less exposure to highly liquid stocks compared with Morningstar Category peers in recent months. Less-liquid stocks might offer strong ...